OpenVSafe by OpenVAERS
Search V-safe

4J7-19691-05305

5 vaccinations 30 coded responses 63 check-ins 30 free-text entries 1 call case
Sex
Female
Age at first dose
66+
ZIP prefix
212 / MD
Registered
2021-03-08
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-07
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-08
    Registered in v-safe
  3. 2021-03-08
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good · Site: Pain
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-03-09
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-10
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-11
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-12
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-03-13
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-03-14
    Survey response — day 7, dose 1
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-03-21
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-03-28
    Dose 2 — Pfizer-BioNTech
  12. 2021-03-28
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  13. 2021-03-29
    Survey response — days 1–6 daily, dose 2
    MedDRA: No adverse event — Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-03-30
    Survey response — days 1–6 daily, dose 2
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-03-31
    Survey response — days 1–6 daily, dose 2
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-02
    Survey response — days 1–6 daily, dose 2
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-04-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-04-04
    Survey response — day 7, dose 2
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-04-11
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-04-18
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-04-25
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-02
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-05-09
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-06-27
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-09-26
    Survey response — 6 months, dose 2
    MedDRA: Pre-existing disease, Vertigo, Vomiting — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Severe vertigo. Vomiting and violent spinning. Three other family members also experienced this. All of us had history of benign positional vertigo but none of us ever had such long lasting severe episode. Wondering if there have been other reports
    MedDRA releases: 2024-11 · check-in free text available
  27. 2021-09-26
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  28. 2021-09-30
    Dose 3 — Pfizer-BioNTech
  29. 2021-09-30
  30. 2021-10-03
    Survey response — days 1–6 daily, dose 3
    MedDRA: Vertigo — Feeling: Good · Site: Pain
    Free text: None but still have long time vertigo possibly from first two doses
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-10-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  32. 2021-10-05
    Survey response — days 1–6 daily, dose 3
    MedDRA: No adverse event — Feeling: Good
    Free text:
    MedDRA releases: 2024-11 · check-in free text available
  33. 2021-10-06
    Survey response — days 1–6 daily, dose 3
    MedDRA: No adverse event — Feeling: Good
    Free text: No
    MedDRA releases: 2024-11 · check-in free text available
  34. 2021-10-07
    Survey response — day 7, dose 3
    MedDRA: No adverse event — Feeling: Good
    Free text: No
    MedDRA releases: 2024-11 · check-in free text available
  35. 2021-10-14
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-10-21
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-10-28
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-11-04
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  39. 2021-11-11
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  40. 2021-12-30
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-03-31
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  42. 2022-07-25
    Dose 4 — Pfizer-BioNTech
  43. 2022-07-25
    Survey response — day 0, dose 4
    MedDRA: No adverse event — Feeling: Good
    Free text: No. Just got the booster an hour ago
    MedDRA releases: 2024-11 · check-in free text available
  44. 2022-07-26
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Headache
    Adult check-in
  45. 2022-07-27
    Survey response — days 1–6 daily, dose 4
    MedDRA: No adverse event — Feeling: Good
    Free text:
    MedDRA releases: 2024-11 · check-in free text available
  46. 2022-07-28
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  47. 2022-07-29
    Survey response — days 1–6 daily, dose 4
    MedDRA: No adverse event — Feeling: Good
    Free text:
    MedDRA releases: 2024-11 · check-in free text available
  48. 2022-07-30
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  49. 2022-07-31
    Survey response — days 1–6 daily, dose 4
    MedDRA: No adverse event — Feeling: Good
    Free text:
    MedDRA releases: 2024-11 · check-in free text available
  50. 2022-08-01
    Survey response — day 7, dose 4
    MedDRA: No adverse event — Feeling: Good
    Free text:
    MedDRA releases: 2024-11 · check-in free text available
  51. 2022-08-08
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  52. 2022-08-15
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  53. 2022-08-22
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  54. 2022-08-29
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  55. 2022-09-05
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  56. 2022-09-30
    Dose 5 — Pfizer-BioNTech
    Co-administered: Flu
  57. 2022-09-30
    Health check-in — day 0, dose 5
    Feeling: Fair · Site: Pain · None
    Adult check-in
  58. 2022-10-01
    Survey response — days 1–6 daily, dose 5
    MedDRA: No adverse event — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: No
    MedDRA releases: 2024-11 · check-in free text available
  59. 2022-10-02
    Survey response — days 1–6 daily, dose 5
    MedDRA: No adverse event — Feeling: Good
    Free text: No
    MedDRA releases: 2024-11 · check-in free text available
  60. 2022-10-03
    Survey response — days 1–6 daily, dose 5
    MedDRA: No adverse event — Feeling: Good
    Free text:
    MedDRA releases: 2024-11 · check-in free text available
  61. 2022-10-04
    Survey response — days 1–6 daily, dose 5
    MedDRA: No adverse event — Feeling: Good
    Free text: No
    MedDRA releases: 2024-11 · check-in free text available
  62. 2022-10-05
    Survey response — days 1–6 daily, dose 5
    MedDRA: No adverse event — Feeling: Good
    Free text: No
    MedDRA releases: 2024-11 · check-in free text available
  63. 2022-10-06
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  64. 2022-10-07
    Health check-in — day 7, dose 5
    Feeling: Good · None
    Adult check-in
  65. 2022-10-14
    Health check-in — day 14, dose 5
    Feeling: Good
    Adult check-in
  66. 2022-10-21
    Health check-in — day 21, dose 5
    Feeling: Good
    Adult check-in
  67. 2022-10-28
    Health check-in — day 28, dose 5
    Feeling: Good
    Adult check-in
  68. 2022-11-04
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  69. 2022-11-11
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  70. 2022-12-30
    Survey response — 3 months, dose 5
    MedDRA: Eye pruritus, Lacrimation disorder, Lacrimation increased — Feeling: Good
    Free text: Itchy eyes, constant tears, deep purple streaks coming down tear ducts
    MedDRA releases: 2024-11 · check-in free text available
  71. 2023-03-31
    Health check-in — 6 months, dose 5
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-07Pfizer-BioNTech
22021-03-28Pfizer-BioNTech
32021-09-30Pfizer-BioNTech No
42022-07-25Pfizer-BioNTech No
52022-09-30Pfizer-BioNTech Flu

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-08

Systemic reaction (other): None

2021-03-09

Systemic reaction (other): None

2021-03-10

Systemic reaction (other): None

2021-03-11

Systemic reaction (other): None

2021-03-12

Systemic reaction (other): None

2021-03-13

Systemic reaction (other): None

Release 5 — day 7, dose 1

2021-03-14

Systemic reaction (other): None

Release 6 — days 1–6 daily, dose 2

2021-03-29

Systemic reaction (other): None

2021-03-30

Systemic reaction (other): None

2021-03-31

Systemic reaction (other): None

2021-04-01

Systemic reaction (other): None

2021-04-02

Systemic reaction (other): None

2021-04-03

Systemic reaction (other): None

Release 6 — day 7, dose 2

2021-04-04

Systemic reaction (other): None

Release 9 — 6 months, dose 2

2021-09-26

Symptoms: Severe vertigo. Vomiting and violent spinning. Three other family members also experienced this. All of us had history of benign positional vertigo but none of us ever had such long lasting severe episode. Wondering if there have been other reports cut off by CDC

Release 9 — days 1–6 daily, dose 3

2021-10-03

Systemic reaction (other): None but still have long time vertigo possibly from first two doses

Release 10 — days 1–6 daily, dose 3

2021-10-05

2021-10-06

Systemic reaction (other): No

Release 10 — day 7, dose 3

2021-10-07

Systemic reaction (other): No

Release 12 — day 0, dose 4

2022-07-25

Systemic reaction (other): No. Just got the booster an hour ago

Release 12 — days 1–6 daily, dose 4

2022-07-27

2022-07-29

2022-07-31

Release 12 — day 7, dose 4

2022-08-01

Release 12 — days 1–6 daily, dose 5

2022-10-01

Systemic reaction (other): No

2022-10-02

Systemic reaction (other): No

2022-10-03

2022-10-04

Systemic reaction (other): No

2022-10-05

Systemic reaction (other): No

Release 12 — 3 months, dose 5

2022-12-30

Symptoms: Itchy eyes, constant tears, deep purple streaks coming down tear ducts

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDEye pruritus · · ✓
SDLacrimation disorder · · ✓
SDLacrimation increased · · ✓
SDPre-existing disease · · ✓
SDVertigo · · ✓
SDVomiting · · ✓
SRONo adverse event ✓ ✓ ✓
SROVertigo · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…